Skip to main content

Table 4 Changes in antidiabetic medication during the study (After 3 months of follow-up) n = 585

From: Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study

Agent Sulfonylurea Biguanide Thiazolidinedione α-Glucosidase inhibitors Sitagliptin
Patients who received additional antidiabetic agent(s) 26 18 9 2 0
Patients who increased dosage 8 26 0 0 86
Patients who decreased dosage 7 4 0 0 2
Patients who stopped receiving agent(s) 8 3 20 0 0